Convergence Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
3,673
+1,759
+92% +$602K 0.11% 99
2026
Q1
$672K Sell
1,914
-62
-3% -$22.1K 0.07% 132
2025
Q4
$647K Sell
1,976
-27
-1% -$8.56K 0.09% 107
2025
Q3
$565K Buy
2,003
+442
+28% +$128K 0.08% 117
2025
Q2
$436K Buy
1,561
+277
+22% +$78.5K 0.07% 124
2025
Q1
$400K Buy
1,284
+268
+26% +$79.1K 0.08% 119
2024
Q4
$265K Buy
1,016
+382
+60% +$113K 0.05% 131
2024
Q3
$204K Buy
+634
New +$207K 0.04% 154

Other funds holding AMGN

Convergence Financial's AMGN Position: Q2 2026 in Review

Convergence Financial increased its Amgen (AMGN) stake by 92% in Q2 2026, buying an estimated $602K and bringing the position to 3,673 shares worth $1.33M. The position accounts for 0.11% of the portfolio, ranked #99.

Convergence Financial first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Convergence Financial held 3,673 shares of Amgen worth $1.33M as of Q2 2026.
  • Convergence Financial bought 1,759 Amgen shares in Q2 2026, an estimated $602K.
  • Amgen made up 0.11% of Convergence Financial's portfolio in Q2 2026, its #99 holding.
  • Convergence Financial first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Convergence Financial's 13F filing for Q2 2026, filed 5 Aug 2026.